Article Data

  • Views 639
  • Dowloads 144

Original Research

Open Access

The infrequent large pelvi-perineal tumors as a surgical dilemma: en bloc resection and long-term results

  • Omaya Abdul Hameed Nassar1,*,

1Surgical Oncology Department, National Cancer Institute, Cairo University, 11796 Cairo, Egypt

DOI: 10.22514/ejgo.2023.052 Vol.44,Issue 4,August 2023 pp.22-27

Submitted: 30 September 2022 Accepted: 03 March 2023

Published: 15 August 2023

*Corresponding Author(s): Omaya Abdul Hameed Nassar E-mail: omaya.nassar@nci.cu.edu.eg

Abstract

To assess long-term results of surgical resections of the sporadic extra-large pelvi-perineal soft tissue tumors, a retrospective series of patients referred to the National Cancer Institute 2001–2022 (tertiary care cancer university hospital in Egypt) was designed. Thirteen patients (3 males) averaged age 57 years had large 29 cm (18–38) pelvi-perineal tumors (10 to the paraanal ischiorectal spaces and 3 to the vulva) plus upper intra-abdominal extensions in 9 patients (69%). Symptoms were nonspecific with delayed presentation that averaged 22-month. The entire underwent combined open abdomino-perineal approach to widely en masse resect tumors plus infiltrated organs. No downsizing hormonal treatment was offered preoperative. Main outcome measures were disease free survival, recurrence pattern and salvage. Extensive pelvic and perineal tumor resection is tough and meticulous but straightforward with minor (Clavien-Dindo Classification (CDC) grade I & II) early and delayed morbidity. Resection extends to hysterectomy, vaginectomy and vascular resection. Histopathology plus immunohistochemistry showed 9-aggressive angiomyxoid tumors (AA), 2-fibromatosis and 2-neurofibromas (NF). Margins of resection are all adequate (R0) except for 2 (Resection margin 1 (R1)). After 50-month median follow up, 8/13 total series (61.5%) were surviving free of disease. 4/9 of AA (44%) had local perineal and/or pelvic recurrences (13–37 months) and all were amenable to curative salvage resections; while, 1/2 patients with fibromatosis died of disseminated peritoneal relapses. No systemic metastases are noticed. Extensive tumors meticulous surgery with experienced pelvic dissection and resection could offer alone long term cure even after recurrences with minor morbidity in a good percent. Fertility sparing resection is not oncologically safe because of the frequent uterine and ovarian invasions.


Keywords

Pelvic neoplasm; Pelvi-perineal tumor; Vulval tumor; Angiomyxoma; Pelvic fibromatosis; Pelvic neurofibroma


Cite and Share

Omaya Abdul Hameed Nassar. The infrequent large pelvi-perineal tumors as a surgical dilemma: en bloc resection and long-term results. European Journal of Gynaecological Oncology. 2023. 44(4);22-27.

References

[1] Fletcher C, Bridge J, Hogendoorn P, Mertens F. World Health Organization classification of tumours of soft tissue and bone. 4th edn. IARC Press: Lyon. 2013.

[2] Mariani A, Nascimento AG, Webb MJ, Sim FH, Podratz KC. Surgical management of desmoid tumors of the female pelvis. Journal of the American College of Surgeons. 2000; 191: 175–183.

[3] Chen H, Zhao H, Xie Y, Jin M. Clinicopathological features and differential diagnosis of aggressive angiomyxoma of the female pelvis. Medicine. 2017; 96: e6820.

[4] Fetsch JF, Laskin WB, Lefkowitz M, Kindblom L, Meis-Kindblom JM. Aggressive angiomyxoma: a clinicopathologic study of 29 female patients. Cancer. 1996; 78: 79–90.

[5] Zou R, Xu H, Shi Y, Wang J, Wang S, Zhu L. Retrospective analysis of clinicopathological features and prognosis for aggressive angiomyxoma of 27 cases in a tertiary center: a 14-year survey and related literature review. Archives of Gynecology and Obstetrics. 2020; 302: 219–229.

[6] Hsieh F, Chuang K, Wu Y, Lin C. Aggressive angiomyxoma—report of a rare male buttock lesion. Plastic and Reconstructive Surgery—Global Open. 2018; 6: e1879.

[7] Celik SU, Hesimov I, Kutlu B, Erkek AB. Aggressive angiomyxoma: a rare tumor of male pelvic cavity. Acta Médica Portuguesa. 2018; 31: 693–696.

[8] Kumar N, Goyal A, Manchanda S, Sharma R, Kumar A, Bansal VK. Aggressive pelvic angiomyxoma and its mimics: can imaging be the guiding light? The British Journal of Radiology. 2020; 93: 20200255.

[9] Nassar OAH. Primary repair of rectovaginal fistulas complicating pelvic surgery by gracilis myocutaneous flap. Gynecologic Oncology. 2011; 121: 610–614.

[10] Seoud M, Abbas J, Kaspar H, Khalil A, Geara F. Long-term survival following aggressive surgery and radiotherapy for pelvic fibromatosis. International Journal of Gynecological Cancer. 2005; 15: 1112–1114.

[11] D. Mitropoulos W.A. Guidelines on reporting and grading of complications after urologic surgical procedures. European Association of Urology. 2014; 50: 233–40.

[12] Figueiredo G, O’Shea A, Neville GM, Lee SI. Rare mesenchymal tumors of the pelvis: imaging and pathologic correlation. RadioGraphics. 2022; 42: 143–158.

[13] Choi H, Park C, Ji Y. Alternative surgical approaches for aggressive angiomyxoma at different sites in the pelvic cavity. Obstetrics & Gynecology Science. 2015; 58: 525.

[14] Fine BA, Munoz AK, Litz CE, Gershenson DM. Primary medical management of recurrent aggressive angiomyxoma of the vulva with gonadotropin-releasing hormone agonist. Gynecologic Oncology. 2001; 81: 120–122.

[15] Chan IM, Hon E, Ngai SW, Ng Ty, Wong LC. Aggressive angiomyxoma in females: is radical resection the only option? Acta Obstetricia et Gynecologica Scandinavica. 2000; 79: 216–220.

[16] Fucà G, Hindi N, Ray-Coquard I, Colia V, Dei Tos AP, Martin-Broto J, et al. Treatment outcomes and sensitivity to hormone therapy of aggressive angiomyxoma: a multicenter, international, retrospective study. The Oncologist. 2019; 24: e536–e541.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top